Protea Biosciences

The partners aim to develop a diagnostic methodology for obtaining cancer cell molecular profiles to help guide immunotherapies.

The companies will market Proteos' protein production services alongside Protea's bioanalytical services.

The mass spectrometry services and instrument firm is working with a Yale pathologist to develop proteomic tests for solid tumors.

The test using proteomic mass spectrometry imaging to separate cancerous spots from benign moles was developed jointly by scientists at Protea and Yale.

Protea will purchase the research services firm with cash and Series A stock, but must first raise at least $10 million in debt or equity.

The partners will use mass spectrometry to study the occupational hazards of inhaling aerosols that are released during welding and electronic manufacturing.

NEW YORK (GenomeWeb) – Protea Biosciences and InSphero today said they will combine their 3D technologies into new products and services to be marketed to the pharmaceutical and biotechnology markets.

NEW YORK (GenomeWeb) – Protea Biosciences Group today said that it has signed an agreement to collaborate with the University of Southampton to identify biomarkers that may indicate a risk of developing Alzheimer's disease.

NEW YORK (GenomeWeb) – Protea Biosciences Group said today that it has undertaken a collaborative research effort with Memorial Sloan Kettering Cancer Center and the Dana-Farber Cancer Institute with an initial focus on lung cancer.


Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.